June 21, 2024
Microbiome Sequencing Service Market

Microbiome Sequencing Service Market is in trends through Microbial Community Profiling

The microbiome sequencing service market involves sequencing and analysis of the microbial composition of various samples such as stool, skin, oral, urogenital, and others. Microbiome sequencing aids in analyzing the microbial community structure and functions by identifying the taxonomic and genetic potential of the microbes present. This helps gain insights into host-microbiome interactions and the role of microbes in health and disease conditions.

The Global Microbiome Sequencing Service Market is estimated to be valued at US$ 4.13 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period of 2024 to 2031.

Key Takeaways

Key players operating in the Microbiome Sequencing Service Market are Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Mérieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen.

The growing demand for microbiome analysis in medical research related to diseases such as diabetes, obesity, cancer, and other disorders has propelled the Microbiome Sequencing Service Market Demand. Many studies have established the association of certain microbes with various conditions, opening opportunities for disease management and treatment through modulation of the gut microbiome.

The market is witnessing global expansion due to increasing collaborations between market players and research institutes. Advancements in sequencing technologies along with declining costs of sequencing are supporting international projects involving cross-country sample collection and analysis. Several regions worldwide are investing in developing microbiome-based diagnostics, therapeutics, and testing services.

Market key trends

Customized microbiome profiling services based on specific disease conditions and sample types is one of the key trends gaining traction in the market. Vendors are offering customized sequencing panels and analysis workflows to meet unique research requirements. Customized profiling aids in disease-specific microbiome investigations with relevance to etiology, progression, and treatment response. This trend is expected to significantly influence research activities in the coming years.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is moderate as establishing new sequencing infrastructure requires large capital investments and technical expertise. However, reducing sequencing costs and expanding applications are likely to attract new players in the industry.

Bargaining power of buyers: The bargaining power of buyers is moderate to high as buyers have several alternative options and switching costs are low. Buyers can negotiate on pricing and demand additional services.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as suppliers of sequencing reagents, kits and equipment have established themselves in the market. Suppliers differentiate their products and control production.

Threat of new substitutes: The threat of substitutes is low as there are limited alternative techniques for large-scale microbial profiling with the same resolution as sequencing.

Competitive rivalry: The competitive rivalry is high with the presence of several global and local players offering customized sequencing services. Players compete on various factors like pricing, turnaround time, data analysis and clinical validation.

Geographical regions

North America dominates the microbiome sequencing service market in terms of value due to the growing clinical applications of microbiome research, increasing government funding for genomics projects, and presence of key market players in the US and Canada.

The Asia Pacific region is poised to be the fastest growing market during the forecast period driven by rising R&D investments, favourable government policies, lower operational costs and expanding healthcare infrastructure in countries like China and India.

*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it.